Jean Nachega is an associate professor of infectious diseases and microbiology and of epidemiology at the University of Pittsburgh School of Public Health and a professor of medicine at Stellenbosch University. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. J.B. Nachega and Others. PEPFAR at 20 — A Game-Changing Impac ... Show More
May 7
NEJM Interview: Christopher Duggan on the effects of ending U.S. foreign-assistance and global health programs.
Christopher Duggan is the director of the Center for Nutrition at Boston Children’s Hospital, a professor of pediatrics at Harvard Medical School, and a professor in the Departments of Nutrition and Global Health and Population at the Harvard T.H. Chan School of Public Health. St ... Show More
7m 6s
Apr 30
NEJM Interview: Arthur Robin Williams on alcohol consumption in the United States and the effects of alcohol taxes.
Arthur Robin Williams is an associate professor of clinical psychiatry at Columbia University and a research scientist at the New York State Psychiatric Institute. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. A.R. Williams. Death and Taxes ... Show More
9m 26s
Oct 2022
Is the pandemic actually over? It’s complicated | Anthony Fauci
“Be spreaders of facts and truths,” says scientist and immunologist Dr. Anthony Fauci. Having advised seven US presidents on various disease outbreaks including COVID-19, he shares insights on the present and future of pandemics, backed up by decades of experience in public healt ... Show More
29m 17s
Oct 2021
Erika Augustine, MD, MS on pivoting research for rare disease patients during the COVID-19 pandemic and beyond
Dr. Erika Augustine, MD, MS, shares about research challenges during the pandemic and how remote patient monitoring continues to evolve to provide patient access and safety. Dr. Augustine is associate chief science officer and director of the clinical trials unit at Kennedy Krieg ... Show More
19m 19s
Jun 2021
Yale’s Dr Risch on Early Treatment
Dr Harvey Risch discusses pandemic strategy and early treatment of coronavirus with RFK Jr in this episode. Risch told Newsweek: “once the virus became endemic, lockdown is counterproductive.”
Harvey A. Risch, M.D., Ph.D., professor of epidemiology, was awarded a $3.65 million Na ... Show More
1h 9m
Oct 2022
Crimes of the COVID-19 Pandemic - Discussion Between Francis Boyle & Dr. Mercola
In this interview, repeat guest Francis Boyle — whose background includes an undergraduate degree from the University of Chicago, a juris doctor (lawyer) degree from Harvard and a Ph.D. in political science — shares his views on the latest efforts to instill fear in the public, t ... Show More
1 h
Jul 2022
HIV and COVID-19 – What We’ve Learned
How has our knowledge of COVID-19 and how it affects people with HIV evolved? IDSA board member Max Brito, MD, FIDSA of the University of Illinois at Chicago and HIVMA board member Rachel Bender Ignacio, MD, FIDSA of the University of Washington discuss the latest COVID-19 clinic ... Show More
25m 55s
Sep 2021
Herd Immunity: How Far Back Has the Delta Variant Set Us?
In this episode, Dr. Ricardo Franco, Assistant Professor of Medicine at the University of Alabama at Birmingham, and Dr. Josh Barocas, Associate Professor of Medicine and Infectious Diseases Physician at the University of Colorado School of Medicine, examine the COVID-19 Delta va ... Show More
26m 24s
Feb 2022
How do we measure quality of care? A conversation on EHRs and research, with A.J. Holmgren, PhD.
A.J. Holmgren, PhD, an assistant professor in the department of medicine at UC San Francisco, discusses EHR quality measurement, quality of care and patient outcomes. This episode is part of the Health IT series by the AMA-MSS Committee on Health Information Technology, hosted by ... Show More
26m 16s
Dec 2021
After 12 Years, NIH Director Francis S. Collins, MD, PhD, Seeks His Next Chapter
JAMA Medical News Associate Managing Editor Jennifer Abbasi talks with physician-geneticist Francis S. Collins, MD, PhD, as he steps down as director of the National Institutes of Health (NIH) and returns full-time to his laboratory at the National Human Genome Research Institute ... Show More
35m 51s